Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Fabbri

Showing results (71-80 of 92) with videos related to

Pageof 10
Sort By:
Neoplasia (New York, N.Y.)|April 2, 2005
Cellular basis of antiproliferative and antitumor activity of the novel camptothecin derivative, gimatecan, in bladder carcinoma modelsPaola Ulivi, Wainer Zoli, Francesco Fabbri, et al.
Diagnostics (Basel, Switzerland)|April 3, 2021
Detection and Investigation of Extracellular Vesicles in Serum and Urine Supernatant of Prostate Cancer PatientsSamanta Salvi, Erika Bandini, Silvia Carloni, et al.
Frontiers in Cell and Developmental Biology|December 7, 2020
miR-9-5p as a Regulator of the Androgen Receptor Pathway in Breast Cancer Cell LinesErika Bandini, Francesca Fanini, Ivan Vannini, et al.
Frontiers in Molecular Biosciences|November 25, 2021
Early Detection and Investigation of Extracellular Vesicles Biomarkers in Breast CancerErika Bandini, Tania Rossi, Emanuela Scarpi, et al.
Cancers|October 13, 2021
A Specific Host/Microbial Signature of Plasma-Derived Extracellular Vesicles Is Associated to Thrombosis and Marrow Fibrosis in Polycythemia VeraMartina Barone, Monica Barone, Francesca Ricci, et al.
Molecular Therapy. Methods & Clinical Development|June 5, 2023
Analysis of EVs from patients with advanced pancreatic cancer identifies antigens and miRNAs with predictive valueIvan Vannini, Tania Rossi, Mattia Melloni, et al.
Cancer Chemotherapy and Pharmacology|March 26, 2017
Phase Ib dose-finding trial of lapatinib plus pegylated liposomal doxorubicin in advanced HER2-positive breast cancerAndrea Rocca, Lorenzo Cecconetto, Alessandro Passardi, et al.
Frontiers in Oncology|February 1, 2021
Immunosenescence in Testicular Cancer Survivors: Potential Implications of Cancer Therapies and Psychological DistressSilvia De Padova, Milena Urbini, Giuseppe Schepisi, et al.
Bone|June 24, 2014
CSF-1 blockade impairs breast cancer osteoclastogenic potential in co-culture systemsChiara Liverani, Laura Mercatali, Chiara Spadazzi, et al.
Frontiers in Oncology|December 13, 2021
An Abnormal Host/Microbiomes Signature of Plasma-Derived Extracellular Vesicles Is Associated to Polycythemia VeraMonica Barone, Martina Barone, Francesca Ricci, et al.
Pageof 10

Showing results (71-80 of 92) with videos related to

Sort By:
Pageof 10
Neoplasia (New York, N.Y.)|April 2, 2005
Cellular basis of antiproliferative and antitumor activity of the novel camptothecin derivative, gimatecan, in bladder carcinoma modelsPaola Ulivi, Wainer Zoli, Francesco Fabbri, et al.
Diagnostics (Basel, Switzerland)|April 3, 2021
Detection and Investigation of Extracellular Vesicles in Serum and Urine Supernatant of Prostate Cancer PatientsSamanta Salvi, Erika Bandini, Silvia Carloni, et al.
Frontiers in Cell and Developmental Biology|December 7, 2020
miR-9-5p as a Regulator of the Androgen Receptor Pathway in Breast Cancer Cell LinesErika Bandini, Francesca Fanini, Ivan Vannini, et al.
Frontiers in Molecular Biosciences|November 25, 2021
Early Detection and Investigation of Extracellular Vesicles Biomarkers in Breast CancerErika Bandini, Tania Rossi, Emanuela Scarpi, et al.
Cancers|October 13, 2021
A Specific Host/Microbial Signature of Plasma-Derived Extracellular Vesicles Is Associated to Thrombosis and Marrow Fibrosis in Polycythemia VeraMartina Barone, Monica Barone, Francesca Ricci, et al.
Molecular Therapy. Methods & Clinical Development|June 5, 2023
Analysis of EVs from patients with advanced pancreatic cancer identifies antigens and miRNAs with predictive valueIvan Vannini, Tania Rossi, Mattia Melloni, et al.
Cancer Chemotherapy and Pharmacology|March 26, 2017
Phase Ib dose-finding trial of lapatinib plus pegylated liposomal doxorubicin in advanced HER2-positive breast cancerAndrea Rocca, Lorenzo Cecconetto, Alessandro Passardi, et al.
Frontiers in Oncology|February 1, 2021
Immunosenescence in Testicular Cancer Survivors: Potential Implications of Cancer Therapies and Psychological DistressSilvia De Padova, Milena Urbini, Giuseppe Schepisi, et al.
Bone|June 24, 2014
CSF-1 blockade impairs breast cancer osteoclastogenic potential in co-culture systemsChiara Liverani, Laura Mercatali, Chiara Spadazzi, et al.
Frontiers in Oncology|December 13, 2021
An Abnormal Host/Microbiomes Signature of Plasma-Derived Extracellular Vesicles Is Associated to Polycythemia VeraMonica Barone, Martina Barone, Francesca Ricci, et al.
Pageof 10